Cargando…
TMAO and Gut Microbial-Derived Metabolites TML and γBB Are Not Associated with Thrombotic Risk in Patients with Venous Thromboembolism
Background: The present work evaluates the association between circulating concentrations of Trimethylamine-N-oxide (TMAO), gamma butyrobetaine (γBB), and trimetyllisine (TML) in controls and patients with venous thromboembolism (VTE) with coagulation parameters. Methods: The study involved 54 VTE p...
Autores principales: | Canyelles, Marina, Plaza, Melania, Rotllan, Noemí, Llobet, Dolors, Julve, Josep, Mojal, Sergi, Diaz-Ricart, Maribel, Soria, José Manuel, Escolà-Gil, Joan Carles, Tondo, Mireia, Blanco-Vaca, Francisco, Souto, Joan Carles |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8911412/ https://www.ncbi.nlm.nih.gov/pubmed/35268516 http://dx.doi.org/10.3390/jcm11051425 |
Ejemplares similares
-
Gut Microbiota-Derived TMAO: A Causal Factor Promoting Atherosclerotic Cardiovascular Disease?
por: Canyelles, Marina, et al.
Publicado: (2023) -
Divergent Effects of Glycemic Control and Bariatric Surgery on Circulating Concentrations of TMAO in Newly Diagnosed T2D Patients and Morbidly Obese
por: Canyelles, Marina, et al.
Publicado: (2022) -
NAD+-Increasing Strategies to Improve Cardiometabolic Health?
por: Blanco-Vaca, Francisco, et al.
Publicado: (2022) -
Trimethylamine N-Oxide: A Link among Diet, Gut Microbiota, Gene Regulation of Liver and Intestine Cholesterol Homeostasis and HDL Function
por: Canyelles, Marina, et al.
Publicado: (2018) -
Therapeutic Potential of Emerging NAD+-Increasing Strategies for Cardiovascular Diseases
por: Rotllan, Noemi, et al.
Publicado: (2021)